Arcutis Biotherapeutics
ARQT
ARQT
56 hedge funds and large institutions have $1.02B invested in Arcutis Biotherapeutics in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
11
Increased
21
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$47.4M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$11.4M |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$15.9M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$4.6M |
| 5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$32.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $48K | +$9.76K | +322 | +26% |
|
52
Canada Life
Winnipeg,
Manitoba, Canada
| $37K | +$37K | +1,218 | New |
|
|
AIP
53
Ameritas Investment Partners
Lincoln,
Nebraska
| $27K | – | – | – |
|
54
Bank of Montreal
Toronto,
Ontario, Canada
| $22K | +$22K | +754 | New |
|
55
Osaic Holdings
Scottsdale,
Arizona
| $12K | – | – | – |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | -$31.8K | -540 | -97% |
|
|
MWNA
57
Marshall Wace North America
New York
| – | -$1.23M | -41,315 | Closed |
|
|
CCM
58
CAAS Capital Management
New York
| – | -$668K | -22,413 | Closed |
|
59
Victory Capital Management
San Antonio,
Texas
| – | -$230K | -7,720 | Closed |
|
|
SO
60
STRS Ohio
Columbus,
Ohio
| – | -$80K | -2,700 | Closed |
|